Literature DB >> 3994345

In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.

G S Kobayashi, J R Little, G Medoff.   

Abstract

N-D-Ornithyl amphotericin B methyl ester (N-D-ornithyl AmE) has a lower toxicity for animals than does amphotericin B (AmB), and peak serum levels can be achieved that are fourfold higher than those obtained with an equivalent dose of AmB. However, N-D-ornithyl AmE has one-fourth the in vitro activity and between one-fifth and one-eighth the in vivo activity of AmB. N-D-ornithyl AmE and the corresponding lysyl derivative also lack the immunoadjuvant effects of AmB.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994345      PMCID: PMC176265          DOI: 10.1128/AAC.27.3.302

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Augmentation of murine immune responses by amphotericin B.

Authors:  T J Blanke; J R Little; S F Shirley; R G Lynch
Journal:  Cell Immunol       Date:  1977-09       Impact factor: 4.868

2.  Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia.

Authors:  G Medoff; F Valeriote; R G Lynch; D Schlessinger; G S Kobayashi
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

3.  Brief communication: polyene potentiation of antitumor agents.

Authors:  G Medoff; D Schlessinger; G S Kobayashi
Journal:  J Natl Cancer Inst       Date:  1973-04       Impact factor: 13.506

4.  Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms.

Authors:  G Medoff; M Comfort; G S Kobayashi
Journal:  Proc Soc Exp Biol Med       Date:  1971-11

5.  Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity.

Authors:  R M Lawrence; P D Hoeprich
Journal:  J Infect Dis       Date:  1976-02       Impact factor: 5.226

6.  Comparative in vitro susceptibility of yeasts to amphotericin B and three methyl ester derivatives.

Authors:  D L Oblack; W L Hewitt; W J Martin
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

7.  Amphotericin B pharmacokinetics in humans.

Authors:  A J Atkinson; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

8.  Polyene macrolide derivatives. II. Physical-chemical properties of polyene macrolide esters and their water soluble salts.

Authors:  C P Schaffner; W Mechlinski
Journal:  J Antibiot (Tokyo)       Date:  1972-04       Impact factor: 2.649

9.  Amphotericin B-induced resistance to Schistosoma mansoni.

Authors:  G R Olds; S J Stewart; J J Ellner
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

10.  Immunopotentiating effects of amphotericin B. I. Enhanced contact sensitivity in mice.

Authors:  S F Shirley; J R Little
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

View more
  9 in total

1.  In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.

Authors:  G S Kobayashi; S J Travis; M G Rinaldi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

Review 2.  Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.

Authors:  K N Sorensen; K V Clemons; D A Stevens
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

3.  Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.

Authors:  R M Parmegiani; D Loebenberg; B Antonacci; T Yarosh-Tomaine; R Scupp; J J Wright; P J Chiu; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

4.  Effect of nystatin, amphotericin B and amphotericin B methyl ester on Saccharomyces cerevisiae with different lipid composition.

Authors:  M A de Resende; F Alterthum
Journal:  Mycopathologia       Date:  1990-12       Impact factor: 2.574

5.  Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum.

Authors:  G S Kobayashi; S Travis; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

Review 6.  Amphotericin B nephrotoxicity.

Authors:  R Sabra; R A Branch
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

7.  Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.

Authors:  J R Perfect; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

8.  Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice.

Authors:  G S Kobayashi; S J Travis; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

Review 9.  Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity.

Authors:  Iman Karimzadeh; Hossein Khalili; Shadi Farsaei; Simin Dashti-Khavidaki; Mohammad Mahdi Sagheb
Journal:  Eur J Clin Pharmacol       Date:  2013-01-30       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.